UNC2025 is primarily utilized in the field of cancer research, particularly in studies focusing on the inhibition of the Mer tyrosine kinase (MERTK). This kinase plays a significant role in the survival and proliferation of cancer cells, making it a target for therapeutic intervention. Researchers employ UNC2025 to investigate its potential in suppressing tumor growth, especially in cancers where MERTK is overexpressed, such as certain types of leukemia and solid tumors. Additionally, it is used to explore its effects on enhancing the efficacy of other cancer treatments, including chemotherapy and immunotherapy, by potentially reducing resistance mechanisms. The compound is also valuable in preclinical studies aimed at understanding the broader signaling pathways involved in cancer progression and immune evasion.